Update on ATM Facility
MedPal AI plc has successfully raised approximately £498,225 in gross proceeds through its At-The-Market equity issuance facility, issuing 7,500,000 new ordinary shares at an average price of 6.643p per share. These funds will be allocated as working capital for its online pharmaceutical subsidiary, MedPal Limited, to enhance stock levels, expand product lines, and support marketing initiatives for its pharmacy and clinic operations. The new shares are expected to be admitted to trading on AIM and commence dealings on or around 19 December 2025, bringing the total number of ordinary shares and voting rights to 427,399,640 upon admission.
Select text to share a quote on X · sign in to keep highlights & notes in your MPAL notes
The Company has raised gross proceeds of approximately £498,225 via the ATM facility through the issue of 7,500,000 new ordinary shares ("ATM Shares") at an average price of 6.643p per ATM Share. The proceeds of the ATM facility will provide additional working capital for MedPal AI's recently established online pharmaceutical subsidiary, MedPal Limited, to hold greater levels of stock, expand product lines and to undertake marketing campaigns to grow the pharmacy and clinic parts of the business, MedPal Pharmacy and Medpal.clinic.
The announcement of 4 December 2025 can be viewed here irtools.co.uk/90/story/3ba161d5-8560-4c6d-8de9-a40e8eb9f1c1
Admission and Voting Rights
Application has been made for the 7,500,000 ATM Shares to be admitted to trading on AIM ("Admission"). Admission is expected to become effective and dealings in the ATM Shares are expected to commence on or around 19 December 2025.
Upon Admission, the Company's issued ordinary share capital will consist of 427,399,640 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, from Admission the total number of Ordinary Shares and voting rights in the Company will be 427,399,640. With effect from Admission, this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The Directors of the Company are responsible for the contents of this announcement.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.